Researchers from Queen Mary University of London have found that a medication originally developed for glycemic control can reverse serious heart damage—not by controlling blood sugar as originally ...

Heart failure remains a substantial burden for patients due to its high prevalence and limited therapeutic options. Heart failure is classified into two major clinical subtypes—heart failure with ...

The zebrafish has emerged as a robust vertebrate model for studying cardiac electrophysiology and pharmacology, owing to its genetic tractability, optical transparency during early stages, and ...

The U.S. Food and Drug Administration (FDA) on Thursday extended the Prescription Drug User Fee Act (PDUFA) action date for the New Drug Application (NDA) for Cytokinetics Inc's (NASDAQ:CYTK) ...

Cytokinetics aims to compete with a Bristol Myers Squibb heart drug projected to become a blockbuster seller, and the company’s value proposition is that its drug candidate has a potential safety edge ...

When researchers at Henry Ford Medical Center began examining medical records of over 7,000 stroke survivors, they discovered something extraordinary about common diabetes medications. Their findings ...

Cytokinetics Inc. won US approval for a drug to treat a deadly heart condition, posing a potential threat to sales of a similar Bristol Myers Squibb Co. treatment that’s expected to be a key growth ...

How would you summarize your study for a lay audience? Heart failure remains a substantial burden for patients due to its high prevalence and limited therapeutic options. Heart failure is classified ...